{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:59:46Z","timestamp":1793771986754,"version":"4.6.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Myelodysplastic syndrome disease (MDS) is caused by the successive acquisition of mutations and thus displays a variable risk for progression to AML. Mutations in\n                    <jats:italic>CEBPA<\/jats:italic>\n                    are commonly associated with a high risk of disease progression, but whether they are causative for AML development is unclear. To analyse the molecular basis of disease progression we generated MDS patient-derived induced pluripotent stem cells from a low risk male patient harbouring\n                    <jats:italic>RUNX1<\/jats:italic>\n                    \/\n                    <jats:italic>SRSF2<\/jats:italic>\n                    mutations. This experimental model faithfully recapitulates the patient disease phenotypes upon hematopoietic differentiation. Introduction of a frameshift mutation affecting the C\/EBP\u03b1 bZIP domain in cells from low-risk stages mimicks disease progression by reducing clonogenicity of myeloid cells, blocking granulopoiesis and increasing erythroid progenitor self-renewal capacity. The acquisition of this mutation reshapes the chromatin landscape at distal cis-regulatory regions and promotes changes in cellular composition as observed by single cell RNAseq. Mutant C\/EBP\u03b1 is therefore causative for MDS disease progression. Our work identifies mutant\n                    <jats:italic>CEBPA<\/jats:italic>\n                    as causative for MDS disease progression, providing a new isogenic MDS experimental model for drug screening to improve diagnostic and therapeutic strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-60192-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:01:59Z","timestamp":1751353319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression"],"prefix":"10.1038","volume":"16","author":[{"given":"Ruba","family":"Almaghrabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Alyahyawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8738-9693","authenticated-orcid":false,"given":"Peter","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8005-2860","authenticated-orcid":false,"given":"Syed A.","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6471-1468","authenticated-orcid":false,"given":"Khadidja","family":"Habel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-9025","authenticated-orcid":false,"given":"Carl","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bayley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3464-793X","authenticated-orcid":false,"given":"George J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turki","family":"Sobahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Baghdadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8761-4280","authenticated-orcid":false,"given":"Arwa F.","family":"Flemban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2992-8497","authenticated-orcid":false,"given":"Saeed M.","family":"Kabrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Torres-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7002-417X","authenticated-orcid":false,"given":"Eirini P.","family":"Papapetrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9875-1421","authenticated-orcid":false,"given":"Ildem","family":"Akerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5464-2602","authenticated-orcid":false,"given":"Manoj","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6735-0038","authenticated-orcid":false,"given":"Eva","family":"Barragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-5226","authenticated-orcid":false,"given":"Dominique","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-0825","authenticated-orcid":false,"given":"Constanze","family":"Bonifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5582-8575","authenticated-orcid":false,"given":"Paloma","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"60192_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405 (2016).","journal-title":"Blood"},{"key":"60192_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0085-4","volume":"8","author":"DP Steensma","year":"2018","unstructured":"Steensma, D. P. Myelodysplastic syndromes current treatment algorithm 2018. Blood Cancer J. 8, 47 (2018).","journal-title":"Blood Cancer J."},{"key":"60192_CR3","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","volume":"366","author":"MJ Walter","year":"2012","unstructured":"Walter, M. J. et al. Clonal architecture of secondary acute myeloid leukemia. N. Engl. J. Med. 366, 1090\u20131098 (2012).","journal-title":"N. Engl. J. Med."},{"key":"60192_CR4","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1182\/blood-2012-10-462440","volume":"121","author":"RB Walter","year":"2013","unstructured":"Walter, R. B. et al. Significance of FAB subclassification of \u201cacute myeloid leukemia, NOS\u201d in the 2008 WHO classification: analysis of 5848 newly diagnosed patients. Blood 121, 2424\u20132431 (2013).","journal-title":"Blood"},{"key":"60192_CR5","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil, E. et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122, 3616\u20133627 (2013).","journal-title":"Blood"},{"key":"60192_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach, T. et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 28, 241\u2013247 (2014).","journal-title":"Leukemia"},{"key":"60192_CR7","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/17474086.2020.1819233","volume":"13","author":"JP Bewersdorf","year":"2020","unstructured":"Bewersdorf, J. P. & Zeidan, A. M. Management of higher risk myelodysplastic syndromes after hypomethylating agents failure: are we about to exit the black hole?. Expert Rev. Hematol. 13, 1131\u20131142 (2020).","journal-title":"Expert Rev. Hematol."},{"key":"60192_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nbt.3178","volume":"33","author":"AG Kotini","year":"2015","unstructured":"Kotini, A. G. et al. Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells. Nat. Biotechnol. 33, 646\u2013655 (2015).","journal-title":"Nat. Biotechnol."},{"key":"60192_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1182\/blood.2018884338","volume":"134","author":"J Hsu","year":"2019","unstructured":"Hsu, J. et al. Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes. Blood 134, 186\u2013198 (2019).","journal-title":"Blood"},{"key":"60192_CR10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.stem.2021.01.011","volume":"28","author":"T Wang","year":"2021","unstructured":"Wang, T. et al. Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets. Cell Stem Cell 28, 1074\u20131089 e1077 (2021).","journal-title":"Cell Stem Cell"},{"key":"60192_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","volume":"125","author":"RC Lindsley","year":"2015","unstructured":"Lindsley, R. C. et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood 125, 1367\u20131376 (2015).","journal-title":"Blood"},{"key":"60192_CR12","unstructured":"Capelli, D., Menotti, D., Fiorentini, A., Saraceni, F. & Olivieri, A. in Leukemia (ed Li, W.) (Nature Portfolio, 2022)."},{"key":"60192_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41375-024-02140-x","volume":"38","author":"JA Georgi","year":"2024","unstructured":"Georgi, J. A. et al. Prognostic impact of CEBPA mutational subgroups in adult AML. Leukemia 38, 281\u2013290 (2024).","journal-title":"Leukemia"},{"key":"60192_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1182\/blood.2020009680","volume":"139","author":"F Taube","year":"2022","unstructured":"Taube, F. et al. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome. Blood 139, 87\u2013103 (2022).","journal-title":"Blood"},{"key":"60192_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/bloodadvances.2021004292","volume":"6","author":"S Wakita","year":"2022","unstructured":"Wakita, S. et al. Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia. Blood Adv. 6, 238\u2013247 (2022).","journal-title":"Blood Adv."},{"key":"60192_CR16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/leu.2013.273","volume":"28","author":"A Fasan","year":"2014","unstructured":"Fasan, A. et al. The role of different genetic subtypes of CEBPA mutated AML. Leukemia 28, 794\u2013803 (2014).","journal-title":"Leukemia"},{"key":"60192_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.scr.2017.06.011","volume":"23","author":"K Nishimura","year":"2017","unstructured":"Nishimura, K. et al. Simple and effective generation of transgene-free induced pluripotent stem cells using an auto-erasable Sendai virus vector responding to microRNA-302. Stem Cell Res 23, 13\u201319 (2017).","journal-title":"Stem Cell Res"},{"key":"60192_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nbt.3070","volume":"33","author":"TM Schlaeger","year":"2015","unstructured":"Schlaeger, T. M. et al. A comparison of non-integrating reprogramming methods. Nat. Biotechnol. 33, 58\u201363 (2015).","journal-title":"Nat. Biotechnol."},{"key":"60192_CR19","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1634\/stemcells.2007-1002","volume":"26","author":"H Fong","year":"2008","unstructured":"Fong, H., Hohenstein, K. A. & Donovan, P. J. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells 26, 1931\u20131938 (2008).","journal-title":"Stem Cells"},{"key":"60192_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep01179","volume":"3","author":"R Abujarour","year":"2013","unstructured":"Abujarour, R. et al. Optimized surface markers for the prospective isolation of high-quality hiPSCs using flow cytometry selection. Sci. Rep. 3, 1179 (2013).","journal-title":"Sci. Rep."},{"key":"60192_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature05950","volume":"448","author":"IG Brons","year":"2007","unstructured":"Brons, I. G. et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191\u2013195 (2007).","journal-title":"Nature"},{"key":"60192_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nature05972","volume":"448","author":"PJ Tesar","year":"2007","unstructured":"Tesar, P. J. et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196\u2013199 (2007).","journal-title":"Nature"},{"key":"60192_CR23","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1242\/dev.125.24.5091","volume":"125","author":"D Acampora","year":"1998","unstructured":"Acampora, D. et al. Visceral endoderm-restricted translation of Otx1 mediates recovery of Otx2 requirements for specification of anterior neural plate and normal gastrulation. Development 125, 5091\u20135104 (1998).","journal-title":"Development"},{"key":"60192_CR24","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/nbt1163","volume":"23","author":"KA D\u2019Amour","year":"2005","unstructured":"D\u2019Amour, K. A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534\u20131541 (2005).","journal-title":"Nat. Biotechnol."},{"key":"60192_CR25","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1242\/dev.129.10.2367","volume":"129","author":"M Kanai-Azuma","year":"2002","unstructured":"Kanai-Azuma, M. et al. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 129, 2367\u20132379 (2002).","journal-title":"Development"},{"key":"60192_CR26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1681\/ASN.2013080831","volume":"25","author":"AQ Lam","year":"2014","unstructured":"Lam, A. Q. et al. Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J. Am. Soc. Nephrol. 25, 1211\u20131225 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"60192_CR27","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood-2006-02-003327","volume":"108","author":"MA Vodyanik","year":"2006","unstructured":"Vodyanik, M. A., Thomson, J. A. & Slukvin, I. I. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 108, 2095\u20132105 (2006).","journal-title":"Blood"},{"key":"60192_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nbt.2571","volume":"31","author":"CM Sturgeon","year":"2013","unstructured":"Sturgeon, C. M., Ditadi, A., Clarke, R. L. & Keller, G. Defining the path to hematopoietic stem cells. Nat. Biotechnol. 31, 416\u2013418 (2013).","journal-title":"Nat. Biotechnol."},{"key":"60192_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/JBM.S12257","volume":"1","author":"G Gupta","year":"2010","unstructured":"Gupta, G., Singh, R., Kotasthane, D. S. & Kotasthane, V. D. Myelodysplastic syndromes\/neoplasms: recent classification system based on World Health Organization Classification of Tumors\u2014International Agency for Research on Cancer for Hematopoietic and Lymphoid Tissues. J. Blood Med. 1, 171\u2013182 (2010).","journal-title":"J. Blood Med."},{"key":"60192_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","volume":"20","author":"AG Kotini","year":"2017","unstructured":"Kotini, A. G. et al. Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia. Cell Stem Cell 20, 315\u2013328 e317 (2017).","journal-title":"Cell Stem Cell"},{"key":"60192_CR31","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1182\/blood-2014-10-570234","volume":"125","author":"LT Vo","year":"2015","unstructured":"Vo, L. T. & Daley, G. Q. De novo generation of HSCs from somatic and pluripotent stem cell sources. Blood 125, 2641\u20132648 (2015).","journal-title":"Blood"},{"key":"60192_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/2643-3230.BCD-20-0161","volume":"2","author":"SA Mian","year":"2021","unstructured":"Mian, S. A. et al. Ectopic humanized mesenchymal niche in mice enables robust engraftment of myelodysplastic stem cells. Blood Cancer Discov. 2, 135\u2013145 (2021).","journal-title":"Blood Cancer Discov."},{"key":"60192_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/85820","volume":"27","author":"T Pabst","year":"2001","unstructured":"Pabst, T. et al. Dominant-negative mutations of CEBPA, encoding CCAAT\/enhancer binding protein-alpha (C\/EBPalpha), in acute myeloid leukemia. Nat. Genet. 27, 263\u2013270 (2001).","journal-title":"Nat. Genet."},{"key":"60192_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/ijlh.12819","volume":"40","author":"K Tohyama","year":"2018","unstructured":"Tohyama, K. Present status and perspective of laboratory hematology in Japan: on the standardization of blood cell morphology including myelodysplasia: on behalf of the Japanese Society for Laboratory Hematology. Int. J. Lab. Hematol. 40, 120\u2013125 (2018).","journal-title":"Int. J. Lab. Hematol."},{"key":"60192_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.bbrc.2007.10.071","volume":"364","author":"A Hansson","year":"2007","unstructured":"Hansson, A., Zetterblad, J., van Duren, C., Axelson, H. & Jonsson, J. I. The Lim-only protein LMO2 acts as a positive regulator of erythroid differentiation. Biochem. Biophys. Res. Commun. 364, 675\u2013681 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"60192_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","volume":"51","author":"SA Assi","year":"2019","unstructured":"Assi, S. A. et al. Subtype-specific regulatory network rewiring in acute myeloid leukemia. Nat. Genet. 51, 151\u2013162 (2019).","journal-title":"Nat. Genet."},{"key":"60192_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/01.moh.0000190110.08156.96","volume":"13","author":"BU Mueller","year":"2006","unstructured":"Mueller, B. U. & Pabst, T. C\/EBPalpha and the pathophysiology of acute myeloid leukemia. Curr. Opin. Hematol. 13, 7\u201314 (2006).","journal-title":"Curr. Opin. Hematol."},{"key":"60192_CR38","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nrc1363","volume":"4","author":"C Nerlov","year":"2004","unstructured":"Nerlov, C. C\/EBPalpha mutations in acute myeloid leukaemias. Nat. Rev. Cancer 4, 394\u2013400 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"60192_CR39","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.3646","volume":"48","author":"MR Corces","year":"2016","unstructured":"Corces, M. R. et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat. Genet. 48, 1193\u20131203 (2016).","journal-title":"Nat. Genet."},{"key":"60192_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45691-4","volume":"15","author":"SG Kellaway","year":"2024","unstructured":"Kellaway, S. G. et al. Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth. Nat. Commun. 15, 1359 (2024).","journal-title":"Nat. Commun."},{"key":"60192_CR41","doi-asserted-by":"publisher","first-page":"e44321","DOI":"10.1371\/journal.pone.0044321","volume":"7","author":"S Matarraz","year":"2012","unstructured":"Matarraz, S. et al. The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes is associated with the diagnostic and patient outcome. PLoS ONE 7, e44321 (2012).","journal-title":"PLoS ONE"},{"key":"60192_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/cyto.b.21946","volume":"100","author":"SGC Mestrum","year":"2021","unstructured":"Mestrum, S. G. C. et al. Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS\/MPN diseases. Differences between MDS and MDS\/MPN. Cytometry B Clin. Cytom. 100, 322\u2013330 (2021).","journal-title":"Cytometry B Clin. Cytom."},{"key":"60192_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2643-3230.BCD-21-0050","volume":"3","author":"AA Petti","year":"2022","unstructured":"Petti, A. A. et al. Genetic and transcriptional contributions to relapse in normal karyotype acute myeloid leukemia. Blood Cancer Discov. 3, 32\u201349 (2022).","journal-title":"Blood Cancer Discov."},{"key":"60192_CR44","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.cell.2015.11.013","volume":"163","author":"F Paul","year":"2015","unstructured":"Paul, F. et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell 163, 1663\u20131677 (2015).","journal-title":"Cell"},{"key":"60192_CR45","doi-asserted-by":"publisher","first-page":"107691","DOI":"10.1016\/j.celrep.2020.107691","volume":"31","author":"M Nafria","year":"2020","unstructured":"Nafria, M. et al. Expression of RUNX1-ETO rapidly alters the chromatin landscape and growth of early human myeloid precursor cells. Cell Rep. 31, 107691 (2020).","journal-title":"Cell Rep."},{"key":"60192_CR46","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert, K. et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17, 1086\u20131093 (2011).","journal-title":"Nat. Med."},{"key":"60192_CR47","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1634\/stemcells.2005-0185","volume":"24","author":"T Jaatinen","year":"2006","unstructured":"Jaatinen, T. et al. Global gene expression profile of human cord blood-derived CD133+ cells. Stem Cells 24, 631\u2013641 (2006).","journal-title":"Stem Cells"},{"key":"60192_CR48","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1001\/jama.2010.1862","volume":"304","author":"AJ Gentles","year":"2010","unstructured":"Gentles, A. J., Plevritis, S. K., Majeti, R. & Alizadeh, A. A. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 304, 2706\u20132715 (2010).","journal-title":"JAMA"},{"key":"60192_CR49","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJMoa040465","volume":"350","author":"PJ Valk","year":"2004","unstructured":"Valk, P. J. et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Engl. J. Med. 350, 1617\u20131628 (2004).","journal-title":"N. Engl. J. Med."},{"key":"60192_CR50","doi-asserted-by":"publisher","unstructured":"Chung, S. S. et al. CD99 is a therapeutic target on disease stem cells in myeloid malignancies. Sci. Transl. Med. 9, https:\/\/doi.org\/10.1126\/scitranslmed.aaj2025 (2017).","DOI":"10.1126\/scitranslmed.aaj2025"},{"key":"60192_CR51","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3324\/haematol.2018.207001","volume":"105","author":"VP Vaikari","year":"2020","unstructured":"Vaikari, V. P. et al. Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia. Haematologica 105, 999\u20131012 (2020).","journal-title":"Haematologica"},{"key":"60192_CR52","doi-asserted-by":"publisher","unstructured":"Almotiri, A. et al. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia. J. Clin. Investig. 131, https:\/\/doi.org\/10.1172\/JCI129115 (2021).","DOI":"10.1172\/JCI129115"},{"key":"60192_CR53","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1038\/onc.2008.175","volume":"27","author":"HC Suh","year":"2008","unstructured":"Suh, H. C. et al. Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo. Oncogene 27, 5612\u20135623 (2008).","journal-title":"Oncogene"},{"key":"60192_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7840","volume":"6","author":"M Papaspyridonos","year":"2015","unstructured":"Papaspyridonos, M. et al. Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation. Nat. Commun. 6, 6840 (2015).","journal-title":"Nat. Commun."},{"key":"60192_CR55","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1074\/jbc.273.14.8278","volume":"273","author":"RW Deed","year":"1998","unstructured":"Deed, R. W., Jasiok, M. & Norton, J. D. Lymphoid-specific expression of the Id3 gene in hematopoietic cells. Selective antagonism of E2A basic helix-loop-helix protein associated with Id3-induced differentiation of erythroleukemia cells. J. Biol. Chem. 273, 8278\u20138286 (1998).","journal-title":"J. Biol. Chem."},{"key":"60192_CR56","doi-asserted-by":"publisher","first-page":"e0154480","DOI":"10.1371\/journal.pone.0154480","volume":"11","author":"Q Zhao","year":"2016","unstructured":"Zhao, Q. et al. Combined Id1 and Id3 Deletion Leads to Severe Erythropoietic Disturbances. PLoS ONE11, e0154480 (2016).","journal-title":"PLoS ONE"},{"key":"60192_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5822-y","volume":"19","author":"HH Huang","year":"2019","unstructured":"Huang, H. H. et al. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. BMC Cancer 19, 617 (2019).","journal-title":"BMC Cancer"},{"key":"60192_CR58","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.stem.2015.08.008","volume":"17","author":"M Iwasaki","year":"2015","unstructured":"Iwasaki, M., Liedtke, M., Gentles, A. J. & Cleary, M. L. CD93 marks a non-quiescent human leukemia stem cell population and is required for development of MLL-rearranged acute myeloid leukemia. Cell Stem Cell 17, 412\u2013421 (2015).","journal-title":"Cell Stem Cell"},{"key":"60192_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20717-9","volume":"12","author":"C Larrue","year":"2021","unstructured":"Larrue, C. et al. Adrenomedullin\u2013CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells. Nat. Commun. 12, 422 (2021).","journal-title":"Nat. Commun."},{"key":"60192_CR60","doi-asserted-by":"publisher","unstructured":"Gluexam, T. et al. CGRP signaling via CALCRL increases chemotherapy resistance and stem cell properties in acute myeloid leukemia. Int. J. Mol. Sci. 20, https:\/\/doi.org\/10.3390\/ijms20235826 (2019).","DOI":"10.3390\/ijms20235826"},{"key":"60192_CR61","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1080\/10428190802129918","volume":"49","author":"A Kracmarova","year":"2008","unstructured":"Kracmarova, A., Cermak, J., Brdicka, R. & Bruchova, H. High expression of ERCC1, FLT1, NME4 and PCNA associated with poor prognosis and advanced stages in myelodysplastic syndrome. Leuk. Lymphoma 49, 1297\u20131305 (2008).","journal-title":"Leuk. Lymphoma"},{"key":"60192_CR62","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.exphem.2009.03.001","volume":"37","author":"N Barbarroja","year":"2009","unstructured":"Barbarroja, N. et al. Additive effect of PTK787\/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia. Exp. Hematol. 37, 679\u2013691 (2009).","journal-title":"Exp. Hematol."},{"key":"60192_CR63","doi-asserted-by":"publisher","first-page":"65837","DOI":"10.18632\/oncotarget.11670","volume":"7","author":"CJ Yeom","year":"2016","unstructured":"Yeom, C. J. et al. LY6E: a conductor of malignant tumor growth through modulation of the PTEN\/PI3K\/Akt\/HIF-1 axis. Oncotarget 7, 65837\u201365848 (2016).","journal-title":"Oncotarget"},{"key":"60192_CR64","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41375-022-01744-5","volume":"37","author":"A Adamo","year":"2023","unstructured":"Adamo, A. et al. Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia. Leukemia 37, 102\u2013112 (2023).","journal-title":"Leukemia"},{"key":"60192_CR65","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ccr.2013.09.018","volume":"24","author":"H Zhang","year":"2013","unstructured":"Zhang, H. et al. Sox4 is a key oncogenic target in C\/EBPalpha mutant acute myeloid leukemia. Cancer Cell 24, 575\u2013588 (2013).","journal-title":"Cancer Cell"},{"key":"60192_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1182\/blood-2010-02-270181","volume":"117","author":"N Kato","year":"2011","unstructured":"Kato, N. et al. Two types of C\/EBPalpha mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models. Blood 117, 221\u2013233 (2011).","journal-title":"Blood"},{"key":"60192_CR67","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/gcc.10185","volume":"37","author":"J Snaddon","year":"2003","unstructured":"Snaddon, J. et al. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2. Genes Chromosomes Cancer 37, 72\u201378 (2003).","journal-title":"Genes Chromosomes Cancer"},{"key":"60192_CR68","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood.V99.4.1332","volume":"99","author":"AF Gombart","year":"2002","unstructured":"Gombart, A. F. et al. Mutations in the gene encoding the transcription factor CCAAT\/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias. Blood 99, 1332\u20131340 (2002).","journal-title":"Blood"},{"key":"60192_CR69","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1158\/2643-3230.BCD-22-0167","volume":"4","author":"AG Kotini","year":"2023","unstructured":"Kotini, A. G. et al. Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of human acute myeloid leukemia. Blood Cancer Discov. 4, 318\u2013335 (2023).","journal-title":"Blood Cancer Discov."},{"key":"60192_CR70","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.stemcr.2018.03.020","volume":"10","author":"CJ Chang","year":"2018","unstructured":"Chang, C. J. et al. Dissecting the contributions of cooperating gene mutations to cancer phenotypes and drug responses with patient-derived iPSCs. Stem Cell Rep. 10, 1610\u20131624 (2018).","journal-title":"Stem Cell Rep."},{"key":"60192_CR71","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.leukres.2003.12.004","volume":"28","author":"S Michalopoulou","year":"2004","unstructured":"Michalopoulou, S. et al. Impaired clonogenic growth of myelodysplastic bone marrow progenitors in vitro is irrelevant to their apoptotic state. Leuk. Res. 28, 805\u2013812 (2004).","journal-title":"Leuk. Res."},{"key":"60192_CR72","doi-asserted-by":"publisher","first-page":"68023","DOI":"10.18632\/oncotarget.12105","volume":"7","author":"B Li","year":"2016","unstructured":"Li, B. et al. Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G\/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R. Oncotarget 7, 68023\u201368032 (2016).","journal-title":"Oncotarget"},{"key":"60192_CR73","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow, S. H., et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 2, International Agency for Research on Cancer: Lyon, France, 2008."},{"key":"60192_CR74","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1128\/MCB.15.10.5830","volume":"15","author":"S Hohaus","year":"1995","unstructured":"Hohaus, S. et al. PU.1 (Spi-1) and C\/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol. Cell. Biol. 15, 5830\u20135845 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"60192_CR75","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood-2003-11-3963","volume":"104","author":"V Heath","year":"2004","unstructured":"Heath, V. et al. C\/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood 104, 1639\u20131647 (2004).","journal-title":"Blood"},{"key":"60192_CR76","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.immuni.2004.11.006","volume":"21","author":"P Zhang","year":"2004","unstructured":"Zhang, P. et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C\/EBP alpha. Immunity 21, 853\u2013863 (2004).","journal-title":"Immunity"},{"key":"60192_CR77","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1182\/bloodadvances.2018024422","volume":"3","author":"M Gerritsen","year":"2019","unstructured":"Gerritsen, M. et al. RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs. Blood Adv. 3, 320\u2013332 (2019).","journal-title":"Blood Adv."},{"key":"60192_CR78","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/blood.V94.1.127.413k07_127_138","volume":"94","author":"AM Lichanska","year":"1999","unstructured":"Lichanska, A. M. et al. Differentiation of the mononuclear phagocyte system during mouse embryogenesis: the role of transcription factor PU.1. Blood 94, 127\u2013138 (1999).","journal-title":"Blood"},{"key":"60192_CR79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00062752-200001000-00002","volume":"7","author":"JL Shepard","year":"2000","unstructured":"Shepard, J. L. & Zon, L. I. Developmental derivation of embryonic and adult macrophages. Curr. Opin. Hematol. 7, 3\u20138 (2000).","journal-title":"Curr. Opin. Hematol."},{"key":"60192_CR80","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1038\/sj.onc.1203661","volume":"19","author":"D Clarke","year":"2000","unstructured":"Clarke, D. et al. In vitro differentiation of c-myb(\u2212\/\u2212) ES cells reveals that the colony forming capacity of unilineage macrophage precursors and myeloid progenitor commitment are c-Myb independent. Oncogene 19, 3343\u20133351 (2000).","journal-title":"Oncogene"},{"key":"60192_CR81","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","volume":"587","author":"LA Miles","year":"2020","unstructured":"Miles, L. A. et al. Single-cell mutation analysis of clonal evolution in myeloid malignancies. Nature 587, 477\u2013482 (2020).","journal-title":"Nature"},{"key":"60192_CR82","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1158\/2643-3230.BCD-21-0155","volume":"3","author":"AJ Menssen","year":"2022","unstructured":"Menssen, A. J. et al. Convergent clonal evolution of signaling gene mutations is a hallmark of myelodysplastic syndrome progression. Blood Cancer Discov. 3, 330\u2013345 (2022).","journal-title":"Blood Cancer Discov."},{"key":"60192_CR83","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1158\/2643-3230.BCD-21-0128","volume":"3","author":"T Guess","year":"2022","unstructured":"Guess, T. et al. Distinct patterns of clonal evolution drive myelodysplastic syndrome progression to secondary acute myeloid leukemia. Blood Cancer Discov. 3, 316\u2013329 (2022).","journal-title":"Blood Cancer Discov."},{"key":"60192_CR84","doi-asserted-by":"crossref","unstructured":"Bachegowda, L. et al. Signal transduction inhibitors in treatment of myelodysplastic syndromes. J. Hematol. Oncol. 6, 50 (2013).","DOI":"10.1186\/1756-8722-6-50"},{"key":"60192_CR85","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1182\/blood-2015-01-624833","volume":"126","author":"X Zhou","year":"2015","unstructured":"Zhou, X. et al. Transmembrane TNF-alpha preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy. Blood 126, 1433\u20131442 (2015).","journal-title":"Blood"},{"key":"60192_CR86","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/sj.leu.2403672","volume":"19","author":"HM Wilson","year":"2005","unstructured":"Wilson, H. M., Lesnikov, V., Plymate, S. R., Ward, J. & Deeg, H. J. High IGFBP-3 levels in marrow plasma in early-stage MDS: effects on apoptosis and hemopoiesis. Leukemia 19, 580\u2013585 (2005).","journal-title":"Leukemia"},{"key":"60192_CR87","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1182\/bloodadvances.2021004845","volume":"5","author":"RA Krimpenfort","year":"2021","unstructured":"Krimpenfort, R. A. & Nethe, M. Canonical Wnt: a safeguard and threat for erythropoiesis. Blood Adv. 5, 3726\u20133735 (2021).","journal-title":"Blood Adv."},{"key":"60192_CR88","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/sj.leu.2404732","volume":"21","author":"JH Mikesch","year":"2007","unstructured":"Mikesch, J. H., Steffen, B., Berdel, W. E., Serve, H. & Muller-Tidow, C. The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia 21, 1638\u20131647 (2007).","journal-title":"Leukemia"},{"key":"60192_CR89","doi-asserted-by":"publisher","unstructured":"Gruszka, A. M., Valli, D. & Alcalay, M. Wnt signalling in acute myeloid leukaemia. Cells 8, https:\/\/doi.org\/10.3390\/cells8111403 (2019).","DOI":"10.3390\/cells8111403"},{"key":"60192_CR90","doi-asserted-by":"publisher","first-page":"615190","DOI":"10.3389\/fonc.2020.615190","volume":"10","author":"M Frenquelli","year":"2020","unstructured":"Frenquelli, M. & Tonon, G. WNT signaling in hematological malignancies. Front. Oncol. 10, 615190 (2020).","journal-title":"Front. Oncol."},{"key":"60192_CR91","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.celrep.2018.07.026","volume":"24","author":"C Ward","year":"2018","unstructured":"Ward, C. et al. Fine-tuning Mybl2 is required for proper mesenchymal-to-epithelial transition during somatic reprogramming. Cell Rep. 24, 1496\u20131511 e1498 (2018).","journal-title":"Cell Rep."},{"key":"60192_CR92","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1002\/term.2337","volume":"12","author":"R Bayley","year":"2018","unstructured":"Bayley, R. et al. The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors. J. Tissue Eng. Regen. Med. 12, e368\u2013e378 (2018).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"60192_CR93","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.scr.2018.04.016","volume":"29","author":"M Hansen","year":"2018","unstructured":"Hansen, M. et al. Efficient production of erythroid, megakaryocytic and myeloid cells, using single cell-derived iPSC colony differentiation. Stem Cell Res. 29, 232\u2013244 (2018).","journal-title":"Stem Cell Res."},{"key":"60192_CR94","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380\u20131389 (2013).","journal-title":"Cell"},{"key":"60192_CR95","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"60192_CR96","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces, M. R. et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat. Methods 14, 959\u2013962 (2017).","journal-title":"Nat. Methods"},{"key":"60192_CR97","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"60192_CR98","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"60192_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"60192_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45839-z","volume":"9","author":"HM Amemiya","year":"2019","unstructured":"Amemiya, H. M., Kundaje, A. & Boyle, A. P. The ENCODE Blacklist: identification of problematic regions of the genome. Sci. Rep. 9, 9354 (2019).","journal-title":"Sci. Rep."},{"key":"60192_CR101","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"60192_CR102","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"60192_CR103","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"60192_CR104","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"60192_CR105","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"60192_CR106","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1093\/bioinformatics\/bth349","volume":"20","author":"AJ Saldanha","year":"2004","unstructured":"Saldanha, A. J. Java Treeview\u2013extensible visualization of microarray data. Bioinformatics 20, 3246\u20133248 (2004).","journal-title":"Bioinformatics"},{"key":"60192_CR107","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"60192_CR108","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"60192_CR109","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60192-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:04:12Z","timestamp":1751353452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60192-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60192"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60192-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.07.24.550349","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"2 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Pablo Menendez is co-founder of OneChain Immunotherapeutics, a spin-off company from the Josep Carreras Leukaemia Institute. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5489"}}